Biovica International AB

Mar 25, 2020

Biovica Strengthens its Commercial Leadership

Dec 06, 2019

Biovica Strengthens Management Team

Nov 20, 2019

Biovica's DiviTum Validated as a Dynamic Biomarker in Metastatic Breast Cancer in Collaboration With Institut Curie, Paris

Sep 18, 2019

DiviTum® Included in New U.S. Cancer Study

May 06, 2019

Biovica: Positive DiviTum® Study Results Published in Highly-renowned European Journal of Cancer

Dec 04, 2018

Biovica Establishes Office in Boston

Jun 04, 2018

Results From AstraZeneca Study Presented Today at ASCO

May 17, 2018

New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB

Apr 17, 2018

Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

Mar 28, 2018

Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum